GIP/GLP-1 (tirzepatide) activates two complementary pathways, potentially amplifying metabolic effects
Gaining this knowledge could greatly improve the health and well-being of millions of postmenopausal women, said Maria Daniela Hurtado Andrade, M.D., Ph.D., assistant professor of medicine and consultant for the Division of Endocrinology at the Mayo Clinic
But as with any new medication option, understanding the differences between the pill and injectable forms is essential for making informed decisions about your care
For now, some discontinue the medication once they have achieved their goal and try to manage maintenance with diet and exercise
Congress for seemingly odd or obscure research (like studying snake venom) that led to major public benefit ( [109] ) ( [110] )
Some patients report reduced appetite so soon after injection that eating becomes secondary